logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Omeros Corp. Spikes on Stock Upgrade

By  +Follow September 16, 2013 7:36AM
Share:
Tickers Mentioned:

Omeros Corp. (OMER) jumped over 60 percent on early trading after Wedbush raised its price target for the stock. The rise constituted Monday's biggest jump for Omeros since October of 2009, and came with especially heavy volume for the small-cap pharma company. With gains reaching over 64 percent, it was a big day for investors in the Seattle-based company that had seen shares bleed off almost 47 percent of their value over the last year.

Wedbush analysts expressed confidence in OMS302, a new drug being developed for use in ophthalmological procedures like cataracts surgeries. With the Food and Drug Administration clamping down on “homebrew” topical solutions used during intraocular lens replacement surgeries, OMS302 appears poised to be the only solution on the market that combines pain relief and pupil dilation.

Wedbush analyst Liana Moussatos was bullish on Omeros, reiterating an outperform rating while raising the price target to $28.

“We recently had a conversation with a high-volume cataract surgeon about the changing regulatory landscape following sterility issues at compound pharmacies. The FDA has indicated that each patient must be given a separate bottle for topical NSAIDs and mydriatic agents. In addition, surgeons are no longer allowed to mix their own homebrews of these agents for use during surgery—a common practice," she said. "The net impact is that the cost of topical NSAIDs and mydriatic agents per cataract procedure is rising—making not only the cost of OMS302 (we estimate ~$250/procedure in the U.S.) to be closer to topical agents, but also making it the only product combining pain relief and mydriasis which complies with these new regulations."

Approval of OMS302 is expected by the middle of next year, and Moussatos has estimated a 90 percent chance the drug gets the final go-ahead. The positive news about the outlook for OMS302 comes on the heels of last week’s news of positive data from phase 1 clinical trials for another Omeros drug, OMS824, an enzyme inhibitor intended for use in patients with Huntington’s disease and schizophrenia.

 

(image ocourtesy of Flickr)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Signup for our daily newsletter and get our best articles emailed right to you!

Results for OMER
Stockaholics
24 Oct 14 14:49:35
Our Penny Stock Alerts Gained 371% In 2 weeks! Sign Up For Free Text Alerts For Our New Pick: http://t.co/Wsu24zYrur $OMER $TACT $ORAN
Stockaholics
24 Oct 14 10:20:38
Our Penny Stock Alerts Gained 371% In 2 weeks! Sign Up For Free Text Alerts For Our New Pick: http://t.co/dLDRavoCi4 $OMER $TACT $ORAN
Red Acre Investments
24 Oct 14 08:43:45
weird that $OMER not in CHMP this month - supposedly had an oral explanation last month - usually leads to CHMP opinion the following mo.
Life Sciences Report
24 Oct 14 08:31:48
"We continue to believe $OMER's OMS824 to be safe and expect the Phase 2 trial to resume"-George Zavoico. Read More: http://t.co/ALVdDRRen9
Penny Stock Secret
23 Oct 14 19:44:25
The Hottest Way to Make Millions From Stock Market.Click HERE http://t.co/SVqoMkrw2z .. $OMER $Z $FFIC
Stockaholics
23 Oct 14 13:11:10
Our Penny Stock Alerts Gained 371% In 2 weeks! Sign Up For Free Text Alerts For Our New Pick: http://t.co/dLDRavoCi4 $OMER $TACT $ORAN
Stockaholics
23 Oct 14 08:30:07
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $OMER $TACT $ORAN
Stockaholics
22 Oct 14 14:41:14
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/H5HPSVIRF1 $OMER $TACT $ORAN
TipRanks
22 Oct 14 14:00:37
5-star analyst Liana Moussatos from Wedbush reiterated a BUY on $OMER. Liana has a 61.1% success rate http://t.co/92FMu0riJC
Smarter Analyst
22 Oct 14 13:06:24
$OMER Maxim Group Comments On Omeros Following Temporary Suspension Of OMS824 Huntington's Disease Trial http://t.co/SI65ehIKG6
Stockaholics
22 Oct 14 10:45:09
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $OMER $TACT $ORAN
HotKeyTrading
22 Oct 14 07:30:04
Gap Downs: $ELP $TLLP $OMER $KALU $RMBS $GOL $GPK $RCII $XRS $SHOO $VSR $NCR $LAKE $CMRX $NTAP http://t.co/Vv2VEn80mr #swingtrading #nasdaq
Michael Broyan
22 Oct 14 06:46:16
low trading volume in $OMER. As always - everybody just hold their positions up to earnings.
Bill Miller
22 Oct 14 06:34:29
@EvntTrader $OMER read this article and see how the apparent need for attention trumps journalism;))) http://t.co/V7gANgniRf
Bill Miller
22 Oct 14 06:28:12
@EvntTrader $OMER "alarming rat results"???-I generally don't read FB either,but such desperation for attention-ridiculously alarmist title!
Evnt Trader
22 Oct 14 05:42:06
$OMER Omeros halts a Phase II Huntington's trial over alarming rat results http://t.co/stDplmXn9i
Investor Wand
22 Oct 14 05:24:58
Is $OMER a BUY? Wedbush Securities Inc. thinks so:http://t.co/Wn7CYavhyY
Bio Stocks™
22 Oct 14 04:48:18
RT @crusadernz: BioPharmCatalyst updates: $GEVA starts rolling NDA. $OMER trial halt + $VRTX $AGIO http://t.co/YopmiArcXU
Shysterjd
22 Oct 14 04:47:11
RT @crusadernz: BioPharmCatalyst updates: $GEVA starts rolling NDA. $OMER trial halt + $VRTX $AGIO http://t.co/YopmiArcXU
BioPharmCatalyst
22 Oct 14 04:45:09
BioPharmCatalyst updates: $GEVA starts rolling NDA. $OMER trial halt + $VRTX $AGIO http://t.co/YopmiArcXU
Don Fishback
22 Oct 14 04:35:30
Academic Algorithms:(Volatility of Volatility) $OPHT, $JAZZ, $CSII, $OMER, $STRP http://t.co/lPePRxYe7S
OptionApps
22 Oct 14 04:35:30
Academic Algorithms:(Volatility of Volatility) $OPHT, $JAZZ, $CSII, $OMER, $STRP http://t.co/9N6734snZF
TalkMarkets
22 Oct 14 03:55:41
Active Stocks: $MELA $SGYP $NVS $OMER $ENTA http://t.co/IELcaLj8uE.
FonsieTrader
22 Oct 14 03:42:44
Parabolic Sar Sell Signals 2/2 $ITUB $LMT $MPW $NQ $NXTD $OCN $OMER $RCII $RMBS $RNO $RTIX $SA $SPWH $TRN $TSU $UPIP http://t.co/WIB5jminhL
TalkMarkets
22 Oct 14 03:02:26
Active Stocks: $MELA $SGYP $NVS $OMER $ENTA http://t.co/IELcaLj8uE
Stockaholics
21 Oct 14 22:17:43
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $OMER $TACT $ORAN
MAISA
21 Oct 14 20:40:49
$OMER_$12.12_provided an update on OMS824 for the treatment of schizophrenia and Huntington's disease
HotKeyTrading
21 Oct 14 19:30:09
Gap Downs: $OMER $KALU $RMBS $GOL $GPK $RCII $XRS $SHOO $VSR $NCR $LAKE $CMRX $NTAP $APT $TKMR http://t.co/XQITF0lRKD #stockpicks #stock
equities.com
21 Oct 14 18:07:13
Omeros Corporation (OMER) Drops 12.3% on October 21 $OMER http://t.co/KhZT8KoRJ2
TalkMarkets
21 Oct 14 15:10:51
Active Stocks: $MELA $SGYP $NVS $OMER $ENTA http://t.co/IELcaLj8uE
Mid▲s †
21 Oct 14 13:04:26
RT @AlertTrade: #GazerAlerts Alert results: $APT +20% $JRJC +4% $LIVE +8% $MNGA +2% $NEON +11% $OMER +4% $RADA +1% $RNO +1% | via http://t.…
Day Trade Alerts
21 Oct 14 13:00:50
#GazerAlerts Alert results: $APT +20% $JRJC +4% $LIVE +8% $MNGA +2% $NEON +11% $OMER +4% $RADA +1% $RNO +1% | via http://t.co/LQqutQYQ2N
Stock Horizon LLC
21 Oct 14 13:00:10
Alert results: http://t.co/peSnwruHbn $APT +20% $JRJC +4% $LIVE +8% $MNGA +2% $NEON +11% $OMER +4% $RADA +1% $RNO +1%
Livevol Community
21 Oct 14 13:00:04
Gainers: $HSTM+19.90% $APT+13.96% $NES+12.38% Losers: $OCN-19.12% $UVXY-14.19% $OMER-13.75% Stock Movers Report: http://t.co/MImGl1GweW
Stockaholics
21 Oct 14 12:54:25
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $OMER $TACT $ORAN
Day Trade Alerts
21 Oct 14 12:04:42
#GazerAlerts Alert updates: $APT +20% $JRJC +4% $LIVE +8% $NEON +10% $OMER +4% | via http://t.co/LQqutQYQ2N
Quantheta
21 Oct 14 12:00:04
#SENTISHIFTDOWN $KO $SPLS $MCD $NQ $LIVE $INTC $MNGA $SAH $QUAD $OMER #quantheta
Stock Horizon LLC
21 Oct 14 12:00:04
Alert updates: $APT +20% $JRJC +4% $LIVE +8% $NEON +10% $OMER +4% http://t.co/FgFxZXP2ok
Hooligan
21 Oct 14 11:45:44
$OMER dont sleep on this one, amazing inst. support even after somewhat less than inspiring news on future pipelines.
Hooligan
21 Oct 14 11:43:34
$OMER impressive ride back from 11.2
The Fly
21 Oct 14 09:57:58
$AAPL $KO $MCD $VZ $TRV $UTX $ILMN $HOG $RNO $OMER On The Fly: Midday Wrap: Full Story http://t.co/cG93mtDmYQ
Livevol Community
21 Oct 14 09:00:04
Gainers: $HSTM+17.44% $NM+10.13% $ILMN+9.43% Losers: $OMER-17.37% $UVXY-12.84% $ESI-12.72% Stock Movers Report: http://t.co/MImGl1GweW
Bill Miller
21 Oct 14 06:46:48
@adamfeuerstein @michael_broyan "Too Simply"-no suggestion of tox, just higher exposure levels than originally observed, anticipated $OMER
Natalie Grover
21 Oct 14 06:30:07
Omeros suspends mid-stage trial of Huntington's drug, shares fall http://t.co/5I8wXV1IWj via @reuters $OMER #FDA #Huntington's
Adam Feuerstein
21 Oct 14 06:16:02
@michael_broyan Simply stated, rats are the proverbial canary in the coal mine. Rat tox is a signal of potential problems in humans. $OMER
The Fly
21 Oct 14 06:15:15
$AAPL $KO $CMG $TXN $HOG $VZ $ILMN $RNO $CVM $OMER $NEON $CE $UTX On The Fly: Pre-market Movers: Full Story http://t.co/SSU3BKHKuW
Michael Broyan
21 Oct 14 06:14:10
Can anyone explain me what is the problem with OMS824 trial? Why we should matter if rats are not ok, but humans are? $OMER @adamfeuerstein
Open Outcrier
21 Oct 14 05:39:04
$OMER (-9.5% pre) Omeros Corp. Suspends Huntington's Trial of OMS824 http://t.co/mPMhqw1M04
Day Trade Alerts
21 Oct 14 05:06:32
Pre Market Movers: $RNO 7.30(-38.60%) $IBIO 1.79(-17.89%) $BRZU 13.83(-13.51%) $OMER 11.96(-13.46%) $PT… via http://t.co/VS8RO1bzXJ
Richard J Law
21 Oct 14 04:30:41
@bradloncar @adamfeuerstein Presumably this is compound specific not target specific tox issue for $OMER PDE10a program?
				
				
By  +Follow September 16, 2013 7:36AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.